← Back to all trials
Completed
NCT05640596
Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
Conditions: Growth Retardation
Sex: All
Ages: N/A – 12 Months
Enrollment: 363
Sponsor: Central Hospital, Nancy, France
Summary
Use of antenatal corticosteroids therapy has increased since the 2000s.
The benefits of such a therapy on premature newborns are scientifically and internationally recognized.Nevertheless, few studies have been conducted to investigate the impact of this antenatal corticosteroid therapy on full-term newborns (> 36 weeks' gestation).The aim of this study is to compare the birth parameters of full-term newborns exposed or not to antenatal corticosteroid therapy.
Eligibility Criteria
Inclusion Criteria:all children exposed to an antenatal corticosteroid therapy before 34 weeks of amenorrhea because of a threat of premature deliveryonly full-term newbornsExclusion Criteria:all children exposed to an antenatal corticosteroid therapy before 34 weeks of amenorrhea for other reasons
Source: ClinicalTrials.gov (NCT05640596). StuddyBuddy aggregates publicly available trial information.